Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-12-15 00:00:00 ET · period of report 2022-12-13 · accession 0001765581-22-000140 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-15 | 2022-12-13 | JAZZ | Pearce Samantha | SVP, Head of Europe, Internat | S - Sale+OE | $155.45 | -531 | 11.3K | -4% | -$82.5K |
| D | 2022-12-15 | 2022-12-13 | JAZZ | Pearce Samantha | SVP, Head of Europe, Internat | M - OptEx | $109.45 | +531 | 11.8K | +5% | +$58.1K |
| D | 2022-12-15 | 2022-12-13 | JAZZ | Pearce Samantha | SVP, Head of Europe, Internat | M - OptEx | $0.00 | -531 | 7,969 | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-12-13 | S | D | 531 | $155.45 | 11,309 | D | — | — | |
| 2 | Common | Ordinary Shares | 2022-12-13 | M | A | 531 | $109.45 | 11,840 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-12-13 | M | D | 531 | $0.00 | 7,969 | D | $109.45 · — to 2030-05-06 | 531 Ordinary Shares | (F2) These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020, 1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter. |